BTIG Maintains Sell on Talis Biomedical, Raises Price Target to $5
Talis Biomedical Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Talis Biomedical (TLIS) and Sarepta Therapeutics (SRPT)
BTIG Remains a Sell on Talis Biomedical (TLIS)
Talis Biomedical (TLIS) Gets a Sell From BTIG
No Data
No Data